Product
Lacutamab
1 clinical trial
2 indications
Indication
Peripheral T Cell LymphomaIndication
Relapse/RecurrenceClinical trial
A Randomized Non Comparative Phase II Study of Lacutamab With GemOx Versus GemOx Alone in Relapsed/Refractory Patients With Peripheral T-cell LymphomaStatus: Recruiting, Estimated PCD: 2025-01-30